Incannex Healthcare IXHL Investor Presentation

Incannex Healthcare Limited is a NASDAQ-listed (IXHL) biopharmaceutical company developing novel cannabinoid pharmaceuticals and psychedelic therapies for patients with unmet medical needs. Re-domiciled from Australia to Delaware in 2023, the company focuses on creating targeted medicines at the intersection of biomedical science and cultural acceptance.